Simulations Plus has released software that aims to use advanced mathematical computer models to predict responses to therapy in…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
An independent committee of experts recommended accelerating a Phase 2 clinical trial of Aisa Pharma‘s experimental oral therapy Profervia…
About 2% of people with scleroderma are positive for more than one disease-associated antibody that targets tissues, causing damaging…
Blocking the activity of calpain proteins reduced scarring in the skin and inflammation in the lungs in a mouse model…
June is Scleroderma Awareness Month, and the scleroderma community is working to increase awareness of this rare disease with…
Therapeutic plasma exchange may help ease digestive issues in people with limited systemic scleroderma (lcSSc), new research indicates. Edward…
Among people with systemic scleroderma (SSc), those who have digital ulcers (DUs) — sores on their fingers or toes…
The European Commission is expected to propose a new governing framework for health data next month, called the European Health…
Treatment with stem cells grown into a skin-like structure called an organoid reduced inflammation and fibrosis (scarring) in a mouse…
Two medications — one for arthritis and the other for diabetes — were able to lessen scarring and inflammation in…